defect in Unc93b1 3d/3d mice, we sought to confirm the antigen-presentation defect reported in the original description of Unc93b1 3d/3d mice by Tabeta et al. 1 . First, we measured the proliferation of ovalbumin (OVA)-specific OT-II T cells after transfer into either wild-type or Unc93b1 3d/3d recipient mice, followed by injection of soluble OVA. In contrast to the findings reported by Tabeta et al. 1 , the OT-II cells proliferated to a similar extent after transfer into an Unc93b1 3d/3d host or a wild-type host, both in terms of the frequency of proliferating cells and average number of divisions (Fig. 1a,b) . Of note, the activation state of cells, monitored by upregulation of expression of the activation marker CD44, was also identical in wild-type and Unc93b1 3d/3d hosts (data not shown).
Next we assessed the ability of Unc93b1 3d/3d hosts to cross-present antigens to CD8 + T cells, using g-irradiated Act-OVA cells (splenocytes expressing membrane-associated OVA under the influence of an actin promoter) as an antigen source, as described in the initial characterization of Unc93b1 3d/3d mice 1 . To ensure that we measured only cross-presentation, we injected OVA-expressing H-2K bm1 cells into wild-type and Unc93b1 3d/3d mice. As H-2K bm1 cells cannot directly present peptides derived from OVA on MHC class I molecules 7 , activation of CD8 + T cells in these conditions must be the result of cross-presentation by host cells. In this setting, we also failed to detect any significant difference between the proliferation profiles of OVA-specific OT-I T cells transferred into wild-type and those of
To the Editor:
Unc93b1 is a critical regulator of signaling by Toll-like receptors (TLRs) 1 . The original description of mice with an inactivating mutation in Unc93b1 (encoding Unc93b1 with substitution of arginine for the histidine at position 412 (H412R); also called '3d mice') reported that these mice have defective signaling via TLR3, TLR7 and TLR9 as well as defects in presentation by major histocompatibility complex (MHC) class II and in cross-presentation 1 . Mutations in Unc93b1 have also been identified as a genetic etiological factor in the encephalitis caused by herpes simplex virus type 1; susceptibility to this encephalitis is associated with defects in TLR signaling 2 . Notably, in vitro studies of human cells have not found defects in presentation by MHC class II after knockdown of Unc93b1 (ref. 3) , which raises the possibility that the role of Unc93b1 in antigen presentation, at least for MHC class II, is limited to mice. Further studies have shown that Unc93b1 controls TLR signaling by acting as a trafficking chaperone, associating with TLRs (such as TLR3, TLR7, TLR8, TLR9, TLR11 and TLR13) and delivering them from the endoplasmic reticulum to endosomes [4] [5] [6] . On the other hand, despite ample studies of mice homozygous for the 3d mutation (Unc93b1 3d/3d mice), mechanistic understanding of the role of Unc93b1 in antigen presentation is still lacking.
Because of the discrepancies between studies of humans and those of mice and the lack of any mechanistic basis for an antigen-presentation . NS, not significant (P > 0.05); *P < 0.05, **P < 0.01 and *** P < 0.001 (one-way analysis of variance followed by a Tukey-Kramer post-test). Data were pooled from at least two independent experiments.
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npg VOLUME 14 NUMBER 11 NOVEMBER 2013 NATURE IMMUNOLOGY cells transferred into Unc93b1 3d/3d hosts (Fig. 1c,d) . Moreover, the activation status of CD8 + T cells also seemed to be similar in both strains. Indeed, upregulation of CD44 and production of interferon-g (IFN-g) after restimulation with peptide ( Fig. 1e,f) or with the phorbol ester PMA and ionomycin (data not shown) were not affected by the genotype of the host. We also studied the proliferation of CD4 + T cells in this setting and found similar proliferation 7 d after activation in wild-type and Unc93b1 3d/3d mice (data not shown).
Together our data do not support the proposal of a direct role for Unc93b1 in antigen presentation, either by MHC class II or by cross-presentation. We did observe defective function of TLR3, TLR7 and TLR9, as originally reported for Unc93b1 3d/3d mice 5 . Given the well-recognized role of TLRs in activating antigen-presenting cells to enhance T cell priming 8 , it is certainly likely that Unc93b1 has an indirect role in T cell activation in some models through its control of the trafficking of TLRs. It is possible that differences in the level of contaminating TLR ligands may account for the discrepancy between our findings and those published by Tabeta et al. 1 . Regardless of the explanation, it is important to establish that there is no evidence to support a function for Unc93b1 beyond control of TLR localization. This clarification is particularly relevant to studies that use Unc93b1 3d/3d mice as a model of multiple TLR deficiencies 9 because any additional functions for Unc93b1 would complicate the interpretation of such studies. Thus, Unc93b1 3d/3d mice, especially when crossed with other TLR-deficient strains, may offer a more straightforward model of multiple TLR deficiencies than the commonly used mice deficient in the adaptors MyD88 and TRIF (Myd88 -/-Trif -/-mice), which also lack signaling downstream of the interleukin 1 receptor family.
METHODS
Methods and any associated references are available in the online version of the paper.
Tabeta et al. respond:
In 2006 we described 3d, an N-ethyl-N-nitrosourea-induced mutation that abolished responses by TLR3, TLR7 and TLR9. We mapped the 3d phenotype on 5,131 meioses to a genomic interval 0.46 Mb in length. We identified the causative missense mutation in Unc93b1, which encodes a multispanning membrane protein of the endoplasmic reticulum 1 . Mice homozygous for the 3d mutation also showed diminished cross-priming of CD8 T cells, which we initially noticed in a second unbiased screen. We observed defective priming of CD4 + T cells as well. To determine whether those anomalies were actually caused by the mutation in Unc93b1, we mapped both priming and cross-priming phenotypes independently and observed perfect concordance between the 3d genotype and the T cellresponse phenotypes in a panel of 52 meioses. All T cell-response assays were performed by researchers 'blinded' to knowledge of 3d genotype and gave overwhelming evidence of linkage (Fig. 1) . The most parsimonious interpretation was that 3d was responsible for all the observed anomalies. Later work demonstrated that 3d antigen-presenting cells (APCs) were less effective than wild-type APCs in stimulating either wild-type or 3d T cells, although 3d T cells showed slightly greater incorporation of thymidine than did wild-type cells regardless of whether the APCs were wild-type or 3d. We took this to suggest compensatory selection of T cells with higher affinity in the 3d environment 2 .
Unc93b1 was later shown to be required for signaling via human TLR3, TLR7 and TLR9 as well 3 and to ensure the trafficking of endosomal TLRs through the endoplasmic reticulum 4 . Noting that knockdown of human UNC93B1 does not result in the disruption of antigen presentation in an in vitro system 5 , Deguine et al. have reexamined the 3d strain and have observed no defect in antigen presentation. Seeking to reconcile our earlier findings with their current observations, they suggest that "differences in the level of contaminating TLR ligands may account for the discrepancy between our findings and those published by Tabeta et al." It is problematic to speak of contamination, because both studies used APCs that were intentionally exposed to cellular RNA and DNA together with antigen. However, in the system used in our earlier work 1 , cross-priming was shown to be undiminished in the absence of TLR signaling 6 .
Two very different explanations for the discrepancy between the data of Deguine et al. presented here and our earlier study 1 have occurred to us. First, it is possible that Deguine et al. have erred in their conclusions. In our earlier study, the priming and cross-priming defects were not absolute in mice homozygous for the 3d mutation 1 , and 'titrated' assays would be needed to reveal the effect of the mutation. Deguine et al. tested only a single quantity of antigen yielding maximum stimulation in both mutant and wild-type cells. It is possible that the phenotype was simply missed. Second, we entertain the possibility that Deguine et al. are correct in their assertion that Unc93b1 plays no direct part in priming or cross-priming. It is possible, then, that the priming defects we observed long ago might have resulted from an unrelated mutation in close proximity to 3d that was ultimately eliminated from the stock acquired by Deguine et al. In November 2010, we used the LifeTechnologies SOLiD platform (which did not exist in 2006) for whole-genome sequencing of DNA from a mouse homozygous for the 3d mutation in our own colony. 78.3% of all coding or splicing nucleotides were covered to a depth of 3 or greater. We calculated heterozygote-detection sensitivity at 55.9%. We successfully investigated 206 of 248 putative mutations by capillary validation sequencing (83.1%). We identified a total of 16 authenticated coding variants across the genome. We observed one of those in the heterozygous state on chromosome 19, distal to the 3d mutation by 6,024,140 base pairs. This was a mutation in Incenp, which encodes the inner centromere protein, related to the survivin complex (data not shown).
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Mice and in vivo T cell activation. C57BL/6, C57BL/6.SJL (CD45.1), B6.C H-2K bm1 and B6.C H-2K bm1 Act-OVA mice (Jackson Laboratories) were bred in our colony. OT-I and OT-II mice (Jackson Laboratories) were bred on a C57BL/6.SJL background in our colony. Unc93b1 3d/3d mice were obtained through the Mutant Mouse Regional Resource Centers (University of California, Davis). All animal experiments were in accordance with University of California Animal Care and Use Committee guidelines. Sex-matched mice 6-10 weeks of age were used for experiments. As all results were analyzed by flow cytometry, no specific 'blinding' method was used.
For in vivo experiments, splenic CD45.1 + OT-I and OT-II T cells were purified through the use of the appropriate Dynabeads negative selection kit (Invitrogen). Purities were over 90% in all experiments, as tested by flow cytometry. Cells were labeled with 2.5 mM or 5 mM CFSE (carboxyfluorescein diacetate succinimidyl ester; Invivogen) for analysis at day 3 or day 7 after activation, respectively, and 5 × 10 6 cells were injected intravenously into wild-type or Unc93b1 3d/3d mice. The next day, mice were given injection of 0.25 mg soluble OVA (Sigma) or saline (as a control), or of 1 × 10 7 irradiated H-2K bm1 Act-OVA cells or H-2K bm1 cells (as a control).
Flow cytometry. At the appropriate time points, spleens and peripheral lymph nodes (inguinal, brachial and axillary) were collected and then dissociated on a cell strainer (70 mm; BD). For restimulation, cells were cultivated for 4 h in the presence of 100 nM OVA peptide (amino acids 332-339) or PMA (phorbol 12-myristate 13-acetate; 50 ng/ml) plus ionomycin (1 mg/ml) and brefeldin A.
Fc receptors were blocked with antibody to CD16/32 (anti-CD16/32; 24G2; UCSF Antibody Core) before samples were staining with the following antibodies (all from eBiosciences): peridinin chlorophyll protein-cyanine 5.5-anti-CD4 (RM4-5), Pacific blue-anti-CD45.1 (A20), allophycocyanin-anti-CD62L (MEL-14), Alexa Fluor 700-anti-CD44 (IM7) and allophycocyanin-Alexa Fluor 780-anti-CD8a (53-6.7). For intracellular staining, cells were fixed with Cytofix/ Cytoperm according to the manufacturer's instructions (BD) before being stained with phycoerythrin-indotricarbocyanine-anti-IFN-g (XMG1.2; BD).
Cells were acquired on an LSR Fortessa and data were analyzed with FlowJo software (version 9.6; Treestar).
Statistical analysis.
On the basis of the original study by Tabeta et al. 1 , we estimated that we would observe differences of over fourfold. With the assumption of a typical s.d. value, a sample size of five should lead to a statistical power of 100% (DSS Research's calculator for a two-tailed test). One-way analysis of variance followed by a Tukey-Kramer post-test with Prism software (version 5; GraphPad) was used for statistical analysis. Direct comparison of wild-type and Unc93b1 3d/3d mice given injection of OVA by an unpaired two-tailed t-test generated similar results. All test samples (n = 5-6) respected the assumption of normality as tested by the Kolmogorov-Smirnov test. P values lower than 0.05 were considered significant. npg
